English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Pharma & Biotech Healthcare & Pharm
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022
Jan 18, 2022 13:00 HKT
Senior Management Increases Shareholdings in EC Healthcare With Strong Confidence in the Group's Future Development
Jan 17, 2022 20:18 HKT
Arcensus has appointed Prof. Dr. Arndt Rolfs as New CEO
Jan 12, 2022 15:00 HKT
Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of the Industry for High Safety and Well Tolerance
Jan 12, 2022 10:26 HKT
SinoMab Awarded the "Best Small and Mid-Cap Company" and "Best CEO" in the Selection of the "6th Hong Kong Golden Stocks Awards" and the "Listed Company with the Most Growth Potential" in the Selection of "2021 Sina Finance Golden Unicorn Best Hong Kong and US Listed Companies"
Jan 11, 2022 16:55 HKT
Clinical Evaluation of LeSoleil Against COVID-19
Jan 11, 2022 12:00 HKT
EC Healthcare expects to achieve a record-high sales volume in third quarter of FY22, Represents more than 40% Y-o-Y increase
Jan 10, 2022 08:18 HKT
B-cell lymphoma clinical trials now open on the TrialWire Platform
Jan 05, 2022 17:10 HKT
Autism clinical trials now open on the TrialWire Platform
Jan 05, 2022 17:00 HKT
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China)
Jan 05, 2022 15:27 HKT
Sirnaomics Ltd., RNA Therapeutics Biopharmaceutical Company with Presence in China and US, Lists on Main Board of SEHK
Dec 30, 2021 15:55 HKT
Sirnaomics Ltd. Announces Proposed Listing on the Main Board of SEHK
Dec 19, 2021 20:48 HKT
Pharmaron recognized with 2 Awards at China Securities Golden Bauhinia Awards Ceremony
Dec 17, 2021 17:45 HKT
Acumen Diagnostics granted Ministry of Health COVID-19 offsite PCR testing license, up to 100 sites island-wide
Dec 16, 2021 11:00 HKT
HMI Group Expands Singapore Presence, Doubles Down on Value-based Care Offering
Dec 10, 2021 13:00 HKT
Biolidics to Commence Commercial Production of its ClearEpi SARS-COV-2 Neutralising Antibody Rapid Test Kit
Dec 09, 2021 08:32 HKT
Avantor Provides Critical Personal Protection Supplies to Vulnerable Populations through NGOs
Dec 06, 2021 10:00 HKT
Acumen Diagnostics' PCR capabilities to tackle Omicron COVID-19 variant
Dec 03, 2021 14:00 HKT
SinoMab Announces the Completion of Enrollment in Phase III Clinical Trial in China for its Flagship Product, SM03
Nov 30, 2021 20:50 HKT
EC Healthcare Acquires Hong Kong Dental Services Chain
Nov 30, 2021 08:35 HKT
Next >>
Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: